NewsRx

Search our medical news database

Congenital Heart Disease

Findings from Congenital Heart Center provide new insights into congenital heart disease

Published in Physician Law Weekly, March 3rd, 2010

According to recent research from London, the United Kingdom, "Exercise intolerance is common in adults with congenital heart disease (ACHD) and affects their prognosis and quality of life, thus becoming an important target for therapies. While exercise training has been widely studied in chronic heart failure, its safety and efficacy in ACHD remain unknown."

"The main obstacle in studies involving physical training and when prescribing exercise, is long-term compliance. Lifestyle changes through behaviour modification are difficult and require adequate physician and patient education on the benefits and types of exercise. Individualised counselling regarding physical...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook